is glp 1 bad for you GLP-1 Agonist: The Good, the and the Ugly Your guide to GLP-1 side

The tendency to fluid retention is highly prevalent in diabetic kidney disease 34

It's science."

NB32: sustained-release naltrexone 32 mg per day plus sustained-release bupropion 360 mg per day combined in fixed-dose tablets Development of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Obesity Glucagon-like peptide 1 receptor agonists (GLP-1RAs), including liraglutide and semaglutide, were initially developed for the treatment of type 2 diabetes but were found to be effective not only in reducing blood glucose levels but body weight as well [1820]

doi: 10.1677/joe.0.1740233 [DOI] [PubMed] [Google Scholar] 117

specifically examined patients with MASLD cirrhosis and type 2 diabetes, finding that GLP-1 receptor agonist initiation was linked to reduced risk of unfavorable liver outcomes including hepatic decompensation events and mortality from any cause (aHR: 0.78, 95%CI: 0.68-0.90) relative to non-users, suggesting potential benefits even in advanced liver disease populations [58]

Added bonus: if powders aren't your thing, Hi-Lyte offers the same straightforward approach in other formats, including liquid electrolyte concentrates, on-the-go Quick Sticks, and Quick Caps